SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-050520
Filing Date
2020-11-04
Accepted
2020-11-04 16:31:13
Documents
46
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q Q3 2020 mack-10q_20200930.htm   iXBRL 10-Q 1278869
2 EX-31.1 mack-ex311_6.htm EX-31.1 8727
3 EX-31.2 mack-ex312_8.htm EX-31.2 8728
4 EX-32.1 mack-ex321_9.htm EX-32.1 5648
5 EX-32.2 mack-ex322_7.htm EX-32.2 5646
  Complete submission text file 0001564590-20-050520.txt   4132353

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mack-20200930.xsd EX-101.SCH 29722
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mack-20200930_cal.xml EX-101.CAL 31703
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mack-20200930_def.xml EX-101.DEF 84929
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mack-20200930_lab.xml EX-101.LAB 244458
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mack-20200930_pre.xml EX-101.PRE 176322
11 EXTRACTED XBRL INSTANCE DOCUMENT mack-10q_20200930_htm.xml XML 605561
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35409 | Film No.: 201287139
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences